Incidence of Guillain–Barré syndrome following SARS‐CoV‐2 immunization: Analysis of a nationwide registry of recipients of 81 million doses of seven vaccines

URL

https://onlinelibrary.wiley.com/doi/10.1111/ene.15504

Authors

Miguel García‐Grimshaw, Javier Andrés Galnares‐Olalde, Omar Yaxmehen Bello‐Chavolla, Anaclara Michel‐Chávez, Arturo Cadena‐Fernández, María Eugenia Briseño‐Godínez, Neftali Eduardo Antonio‐Villa, Isaac Núñez, Alonso Gutiérrez‐Romero, Laura Hernández‐Vanegas, María del Mar Saniger‐Alba, Roger Carrillo‐Mezo, Santa Elizabeth Ceballos‐Liceaga, Guillermo Carbajal‐Sandoval, Fernando Daniel Flores‐Silva, José Luis Díaz‐Ortega, Ricardo Cortes‐Alcalá, José Rogelio Pérez‐Padilla, Hugo López‐Gatell, Erwin Chiquete, Gustavo Reyes‐Terán, Antonio Arauz, and Sergio Iván Valdés‐Ferrer

Published Date

July 16, 2022

Publication

European Journal of Neurology

Organization

Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (Mexico)

Wiley Online Library Terms of Use: https://onlinelibrary.wiley.com/terms-and-conditions

Rules of Use

A. To make Wiley Online Library and the Electronic Products useful, the following rules apply: ...

2. Customers and their Authorized Users will have access to the full text of the Licensed Electronic Products covered by the applicable License. Customers and their Authorized Users may download, search, retrieve, display and view, copy and save to a secure network or other electronic storage media and store or print out single copies of individual articles or items for their own personal use, scholarly, educational or scientific research or internal business use.

Medium

document

Topics

adverse events,COVID-19,demyelination,hospitalizations,neurological disorders,vaccines